Research, Development, And Testing Services - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Research, industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Research, Development, And Testing Services - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Research, Development, And Testing Services
Corporate Insider Buy Sell Ratio (Insider Count) - Research, Development, And Testing Services
Research, Development, And Testing Services - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-07-15 INCY / Incyte Corporation 4 Iyengar Vijay K S - Sale D 69.86 -1,177
2025-07-15 INCY / Incyte Corporation 4 Denton Sheila A. S - Sale D 69.86 -3,330
2025-07-15 INCY / Incyte Corporation 4 Denton Sheila A. M - Exercise D 64.25 3,330
2025-07-15 INCY / Incyte Corporation 4 Tray Thomas F - Taxes D 68.25 -583
2025-07-15 INCY / Incyte Corporation 4 Hoppenot Herve F - Taxes D 68.25 -4,713
2025-07-15 INCY / Incyte Corporation 4 Denton Sheila A. F - Taxes D 68.25 -703
2025-07-15 INCY / Incyte Corporation 4 Stamoulis Christiana F - Taxes D 68.25 -1,445
2025-07-15 INCY / Incyte Corporation 4 Trotta Matteo F - Taxes D 68.25 -182
2025-07-15 INCY / Incyte Corporation 4 Flannelly Barry P F - Taxes D 68.25 -1,141
2025-07-15 INCY / Incyte Corporation 4 CAGNONI PABLO J F - Taxes D 68.25 -2,628
2025-07-15 INCY / Incyte Corporation 4 Stein Steven H F - Taxes D 68.25 -1,596
2025-07-15 INCY / Incyte Corporation 4 Iyengar Vijay K F - Taxes D 68.25 -836
2025-07-15 INCY / Incyte Corporation 4 SWAIN PAULA J F - Taxes D 68.25 -563
2025-07-15 INCY / Incyte Corporation 4 SWAIN PAULA J A - Award D 6,430
2025-07-15 INCY / Incyte Corporation 4 Iyengar Vijay K A - Award D 6,430
2025-07-15 INCY / Incyte Corporation 4 Trotta Matteo A - Award D 5,261
2025-07-15 INCY / Incyte Corporation 4 Tray Thomas A - Award D 4,482
2025-07-15 INCY / Incyte Corporation 4 Stamoulis Christiana A - Award D 11,107
2025-07-15 INCY / Incyte Corporation 4 Stein Steven H A - Award D 12,277
2025-07-15 INCY / Incyte Corporation 4 Denton Sheila A. A - Award D 8,184
2025-07-15 INCY / Incyte Corporation 4 CAGNONI PABLO J A - Award D 17,538
2025-07-15 INCY / Incyte Corporation 4 Issa Mohamed Khairie A - Award D 8,769
2025-07-14 INCY / Incyte Corporation 4 Stein Steven H S - Sale D 68.47 -14,952
2025-07-14 INCY / Incyte Corporation 4 Tray Thomas F - Taxes D 69.98 -692
2025-07-14 INCY / Incyte Corporation 4 Stein Steven H F - Taxes D 69.98 -1,555
2025-07-14 INCY / Incyte Corporation 4 CAGNONI PABLO J F - Taxes D 69.98 -1,280
2025-07-14 INCY / Incyte Corporation 4 Hoppenot Herve F - Taxes D 69.98 -4,961
2025-07-14 INCY / Incyte Corporation 4 Stamoulis Christiana F - Taxes D 69.98 -1,407
2025-07-14 INCY / Incyte Corporation 4 Flannelly Barry P F - Taxes D 69.98 -922
2025-07-14 INCY / Incyte Corporation 4 Iyengar Vijay K F - Taxes D 69.98 -595
2025-07-14 INCY / Incyte Corporation 4 SWAIN PAULA J F - Taxes D 69.98 -444
2025-07-03 INCY / Incyte Corporation 4 Iyengar Vijay K S - Sale D 68.15 -5,935
2025-07-03 INCY / Incyte Corporation 4 Iyengar Vijay K S - Sale D 68.16 -2,682
2025-07-03 INCY / Incyte Corporation 4 Flannelly Barry P S - Sale D 68.15 -10,903
2025-07-02 INCY / Incyte Corporation 4 Denton Sheila A. S - Sale D 68.61 -599
2025-07-02 INCY / Incyte Corporation 4 Denton Sheila A. M - Exercise D 58.06 599
2025-07-02 INCY / Incyte Corporation 4 Stein Steven H F - Taxes D 68.17 -12,714
2025-07-02 INCY / Incyte Corporation 4 Iyengar Vijay K F - Taxes D 68.17 -6,809
2025-07-02 INCY / Incyte Corporation 4 Stamoulis Christiana F - Taxes D 68.17 -11,589
2025-07-02 INCY / Incyte Corporation 4 Tray Thomas F - Taxes D 68.17 -897
2025-07-02 INCY / Incyte Corporation 4 Flannelly Barry P F - Taxes D 68.17 -9,055
2025-07-02 INCY / Incyte Corporation 4 Hoppenot Herve F - Taxes D 68.17 -42,769
2025-07-02 INCY / Incyte Corporation 4 SWAIN PAULA J F - Taxes D 68.17 -6,285
2025-07-02 INCY / Incyte Corporation 4 Meury William A - Award D 36,101
2025-07-01 NOTV / Inotiv, Inc. 4 Neff R Matthew S - Sale D 1.8105 -2,000
2025-06-30 MEDP / Medpace Holdings, Inc. 4 Carley Brian T M - Exercise D 62
2025-06-30 MEDP / Medpace Holdings, Inc. 4 McCarthy Cornelius P. III M - Exercise D 50
2025-06-30 MEDP / Medpace Holdings, Inc. 4 Kraft Robert O. M - Exercise D 57
2025-06-30 INCY / Incyte Corporation 4 BAKER BROS. ADVISORS LP See Footnotes A - Award I 492
2025-06-30 INCY / Incyte Corporation 4 Issa Mohamed Khairie A - Award D 27,812
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)